Stock Risk Measures for Theravance Biopharma Inc
A quantitative factor review as of December 31, 2020.
- Company Info - Description, identity and sector data.
- Share Data - Stock earnings and key dates.
- Market Risk - Beta, size, liquidity and momentum measures.
- Financial Risk - Earnings and dividends.
Updated: January 03, 2021
See how we arrive at an overall risk score of
76
for TBPH below.
TBPH Risk Report
Overview
Our quantitative data points are meant to provide a high-level understanding of
factors in equity risk models for Theravance Biopharma Inc. Portfolio managers use these
models to forecast risk, optimize portfolios and review performance.
We show how TBPH stock compares to 2,000+ US-based stocks, and to
peers in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry.
Please do not consider this data as investment advice. Data is downloaded from
sources we deem reliable, but errors may occur.
Company Info
Business Description
Identity
- Symbol: TBPH
- FactorPad FPID: f48xcn
- SEC CIK: 0001583107
- Share Class FIGI: BBG004HK6YY0
- Location: George town, Grand cayman Cayman Islands
- Web:
Sector and Industry
- Sector: Manufacturing
- Industry: Pharmaceutical Preparation Manufacturing
- SIC Code: 2834
Share Data
Shares
- Shares Outstanding: 63,981,317
Earnings and Dividends
- Trailing 12-month earnings: -4.72
- Next earnings date:
- Dividend yield in last 12 months: 0%
- Ex-dividend date:
Market Risk Measures
Many of the following risk metrics are standardized and transformed into
quantitative factors in institutional-level risk models.
Rankings below represent percentiles from 1 to 100, with 1 being the lowest
rating of risk.
Systematic Risk
Stocks with higher beta exhibit higher sensitivity to the ups and downs
in the market. (↑↑)
-
Beta: 0.79 |
All: 14
|
Sector: 15
|
Industry: 27
Company Size
Stocks with higher market capitalization often have lower risk. (↑↓)
-
Market Capitalization: $1,136,948,003 |
All: 84
|
Sector: 86
|
Industry: 78
Trading Liquidity
Higher average daily dollar volume over the past 30 days implies lower
liquidity risk. (↑↓)
-
Daily Dollar Volume: $5,089,601 |
All: 90
|
Sector: 92
|
Industry: 96
Price Momentum
Higher price momentum stocks, aka recent winners, equate to lower risk for many
investors. (↑↓)
-
Stock Price Change (1-Year): -31.36% |
All: 91
|
Sector: 93
|
Industry: 87
Financial Risk Measures
Style risk factors often include measures of profitability and payout levels.
Earnings Yield
Companies with higher earnings generally provide lower risk. (↑↓)
-
Earnings Yield (E/P): -25.13% |
All: 95
|
Sector: 97
|
Industry: 96
Dividend Yield
Companies with higher dividend yields, if sustaintable, are perceived to
have lower risk. (↑↓)
-
Dividend Yield (D/P): 0% |
All: 83
|
Sector: 78
|
Industry: 57
TBPH stock risk
THERAVANCE BIOPHARMA INC stock beta
TBPH risk report
TBPH f48xcn
TBPH risk analysis
TBPH volatility
THERAVANCE BIOPHARMA INC credit risk
TBPH liquidity risk
TBPH leverage
TBPH valuation
TBPH systematic risk
TBPH specific risk
THERAVANCE BIOPHARMA INC volatility
TBPH analysis
TBPH financial ratio